Related references
Note: Only part of the references are listed.SYK KINASE INHIBITORS IN ALLERGIC DISEASES
Jane Denyer et al.
DRUG NEWS & PERSPECTIVES (2009)
The tyrosine kinase network regulating mast cell activation
Alasdair M. Gilfillan et al.
IMMUNOLOGICAL REVIEWS (2009)
A novel Syk family kinase inhibitor:: Design, synthesis, and structure-activity relationship of 1,2,4-triazolo[4,3-c]pyrimidine and 1,2,4-triazolo[1,5-c]pyrimidine derivatives
Akihito Hirabayashi et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2008)
Identification of the Syk kinase inhibitor R112 by a human mast cell screen
Alexander B. Rossi et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2006)
Modulation of the Fc epsilon receptor I signaling by tyrosine kinase inhibitors: Search for therapeutic targets of inflammatory and allergy diseases
P Luskova et al.
CURRENT PHARMACEUTICAL DESIGN (2004)
The orally available spleen tyrosine kinase inhibitor 2-[7-(3,4-dimethoxyphenyl)-imidazo[1,2-c]pyrimidin-5-ylamino]-nicotinamide dihydrochloride (BAY 61-3606) blocks antigen-induced airway inflammation in rodents
N Yamamoto et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2003)
Discovery and SAR of novel [1,6]naphthyridines as potent inhibitors of Spleen Tyrosine Kinase (SYK)
CL Cywin et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2003)
Share Paper
